These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31021617)

  • 21. Synthesis of bitopic ligands based on fallypride and evaluation of their affinity and selectivity towards dopamine D
    Tian GL; Hsieh CJ; Taylor M; Lee JY; Riad AA; Luedtke RR; Mach RH
    Eur J Med Chem; 2023 Dec; 261():115751. PubMed ID: 37688938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol Motif.
    Gadhiya S; Cordone P; Pal RK; Gallicchio E; Wickstrom L; Kurtzman T; Ramsey S; Harding WW
    ACS Med Chem Lett; 2018 Oct; 9(10):990-995. PubMed ID: 30344905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selectivity and activation of dopamine D3R from molecular dynamics.
    Feng Z; Hou T; Li Y
    J Mol Model; 2012 Dec; 18(12):5051-63. PubMed ID: 22752545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D
    Shaik AB; Kumar V; Bonifazi A; Guerrero AM; Cemaj SL; Gadiano A; Lam J; Xi ZX; Rais R; Slusher BS; Newman AH
    J Med Chem; 2019 Oct; 62(20):9061-9077. PubMed ID: 31526003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current drug treatments targeting dopamine D3 receptor.
    Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F
    Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
    Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
    ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and evaluation of bitopic arylpiperazine-phthalimides as selective dopamine D
    Cao Y; Sun N; Zhang J; Liu Z; Tang YZ; Wu Z; Kim KM; Cheon SH
    Medchemcomm; 2018 Sep; 9(9):1457-1465. PubMed ID: 30288220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists.
    Xu W; Wang X; Tocker AM; Huang P; Reith ME; Liu-Chen LY; Smith AB; Kortagere S
    ACS Chem Neurosci; 2017 Mar; 8(3):486-500. PubMed ID: 27801563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological targeting of G protein-coupled receptor heteromers.
    Moreno E; Casajuana-Martin N; Coyle M; Campos BC; Galaj E; Del Torrent CL; Seyedian A; Rea W; Cai NS; Bonifazi A; Florán B; Xi ZX; Guitart X; Casadó V; Newman AH; Bishop C; Pardo L; Ferré S
    Pharmacol Res; 2022 Nov; 185():106476. PubMed ID: 36182040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Palmitoylation on the carboxyl terminus tail is required for the selective regulation of dopamine D2 versus D3 receptors.
    Zhang X; Le HT; Zhang X; Zheng M; Choi BG; Kim KM
    Biochim Biophys Acta; 2016 Sep; 1858(9):2152-2162. PubMed ID: 27349735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
    Madapa S; Gadhiya S; Kurtzman T; Alberts IL; Ramsey S; Reith M; Harding WW
    Eur J Med Chem; 2017 Jan; 125():255-268. PubMed ID: 27688181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New tetrahydroisoquinoline-based D
    Cordone P; Namballa HK; Muniz B; Pal RK; Gallicchio E; Harding WW
    Bioorg Med Chem Lett; 2021 Jun; 42():128047. PubMed ID: 33882273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
    Ferruz N; Doerr S; Vanase-Frawley MA; Zou Y; Chen X; Marr ES; Nelson RT; Kormos BL; Wager TT; Hou X; Villalobos A; Sciabola S; De Fabritiis G
    Sci Rep; 2018 Jan; 8(1):897. PubMed ID: 29343833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
    Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
    J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a Stereoselective Mechanism for Bitopic Activity by Extended-Length Antagonists of the D
    Moritz AE; Bonifazi A; Guerrero AM; Kumar V; Free RB; Lane JR; Verma RK; Shi L; Newman AH; Sibley DR
    ACS Chem Neurosci; 2020 Oct; 11(20):3309-3320. PubMed ID: 32969645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Affinity Dopamine D3 Receptor (D3R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D3R Knockout Mice.
    Boateng CA; Bakare OM; Zhan J; Banala AK; Burzynski C; Pommier E; Keck TM; Donthamsetti P; Javitch JA; Rais R; Slusher BS; Xi ZX; Newman AH
    J Med Chem; 2015 Aug; 58(15):6195-213. PubMed ID: 26203768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D1/D3 heterodimer.
    Hounsou C; Margathe JF; Oueslati N; Belhocine A; Dupuis E; Thomas C; Mann A; Ilien B; Rognan D; Trinquet E; Hibert M; Pin JP; Bonnet D; Durroux T
    ACS Chem Biol; 2015 Feb; 10(2):466-74. PubMed ID: 25350273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unraveling Activation-Related Rearrangements and Intrinsic Divergence from Ligand-Specific Conformational Changes of the Dopamine D3 and D2 Receptors.
    Lee KH; Shi L
    J Chem Inf Model; 2024 Mar; 64(6):1778-1793. PubMed ID: 38454785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of novel N-sulfonyl-2-indoles that behave as 5-HT
    Saavedra OM; Karila D; Brossard D; Rojas A; Dupuis D; Gohier A; Mannoury la Cour C; Millan MJ; Ortuno JC; Hanessian S
    Bioorg Med Chem; 2017 Jan; 25(1):38-52. PubMed ID: 28029458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the Substitution Pattern at the Basic Center and Geometry of the Amine Fragment on 5-HT
    Grychowska K; Pietruś W; Kulawik L; Bento O; Satała G; Bantreil X; Lamaty F; Bojarski AJ; Gołębiowska J; Nikiforuk A; Marin P; Chaumont-Dubel S; Kurczab R; Zajdel P
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.